Valeant Pharmaceuticals buys Bausch & Lomb

Douglas Bryce, Firoz Ahmed, Amanda Heale

May 28, 2013

Tom Huddleston Jr., The Am Law Daily

Laval, Quebec–based Valeant Pharmaceuticals has said that it has agreed to acquire the contact lens maker [Bausch & Lomb] in a cash deal worth $8.7 billion. The transaction's terms call for Valeant to pay $4.5 billion to a group of Bausch & Lomb investors led by private equity firm Warburg Pincus, with the remaining $4.2 billion earmarked to pay off the target's debt.

Osler's team that is acting as Canadian counsel to Valeant includes firm chair and corporate partner Clay Horner, as well as corporate partner Douglas Bryce, tax partner Firoz Ahmed, and competition partner Peter Glossop. The Osler associates on the deal team are Amanda Heale and Robert Hughes.

To read the full article, please click here

Bloomberg announced the deal on May 29, giving details and naming the Osler partners as Canadian counsel to Valeant.

To read the full article, please click here.